Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...

Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...

All 12 Quarter Horses have been placed on the Steward's List meaning they cannot run in any licensed jurisdiction in North America until the adjudication process has been finalized. Both trainers were ...

Telehealth company Hims & Hers is being called out over its Super Bowl ad going after Big Pharma and popular weight-loss ...

It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...

These are compounded drugs, meaning they haven’t gone through the traditional approval process designed to safeguard against risks to consumers — a point the ad largely glosses over.

These groups operate with near impunity within the borders of countries like Mexico. In contrast, despite its vast resources ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US counterparts.